05:37 AM EST, 11/11/2026 (MT Newswires) -- Eco Animal Health (EAH.L) filed a marketing authorization application with the European Medicines Agency for its Ecovaxxin MG jab against poultry disease mycoplasma gallisepticum. The submission is the British animal health company's second for a poultry vaccine in the European Union, following the jab against mycoplasma synoviae, which launched commercially in July, according to a Wednesday filing. Mycoplasma gallisepticum is a bacterial pathogen that causes chronic respiratory disease in chickens, reducing egg production.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.